NDC 54868-1338

NDC 54868-1338

NDC 54868-1338 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 54868-1338
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 54868-1338-8 [54868133808]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-6 [54868133806]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-1 [54868133801]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-7 [54868133807]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-0 [54868133800]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-2 [54868133802]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-3 [54868133803]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-4 [54868133804]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

NDC 54868-1338-9 [54868133809]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-07-23
Inactivation Date2019-09-24

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.